Clinical Trial Update: Vytorin Treating Uncontrolled Lipids (VyTUL) Study (0653A-122) [Phase 3]

View source ↗

Summary

Phase 3 VyTUL trial evaluating Vytorin for uncontrolled lipids was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Diabetes Mellitus

Drugs mentioned

• Vytorin (ezetimibe/simvastatin)

Snippet

Sponsor: Organon and Co | Conditions: Cardiovascular Diseases, Diabetes Mellitus | Phase 3 | Status: TERMINATED